Pyelonephritis is a bacterial infection of the kidneys. The estimated annual incidence of pyelonephritis is 10.5 million to 25.9 million cases globally (1–3). It is more commonly seen in children, ...
Journal of Nuclear Medicine Technology June 2026, jnmt.126.272186; DOI: https://doi.org/10.2967/jnmt.126.272186 ...
An estimated 3 million PET/CT procedures were performed in the United States in 2017, with over 90% being for oncology care and approximately 10% for assessing myocardial perfusion, neurologic ...
The past year has marked a period of significant growth, collaboration, and strategic investment for the Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS), with a ...
Sincalide (Kinevac) is widely used in conjunction with cholescintigraphy for a variety of clinical indications. Over the years, numerous publications have verified the optimal infusion methodology.
Lung perfusion scintigraphy is a cornerstone for evaluating pulmonary embolism but may reveal unexpected vascular anomalies. Persistent left superior vena cava, a congenital anomaly, can cause a right ...
In 1966, Griffith et al. used “a standard breakfast of ordinary food” labeled with chromium-51 to report the first use of gastric emptying scintigraphy (GES). As the procedure was refined over the ...
SUV is a commonly used PET parameter to measure the uptake of various radiopharmaceuticals, mainly 18 F-FDG, in normal tissues and lesions (1–3). SUV is simply the ratio of activity concentration in ...
Journal of Nuclear Medicine Technology January 2026, jnmt.125.270563; DOI: https://doi.org/10.2967/jnmt.125.270563 ...
In recent years, there has been an influx of new tracers into the field of nuclear medicine and molecular imaging. Most of those that have been Food and Drug Administration–approved for clinical ...
Diuretic renal scintigraphy plays a critical diagnostic role by providing a physiologic means for differentiating between obstructive and nonobstructive hydronephrosis and by assessing the function of ...
Prostate-specific membrane antigen (PSMA) has fundamentally reshaped prostate cancer imaging and therapy, delivering an unprecedented combination of high lesion conspicuity, broad clinical ...